Stock CVKD CADRENAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Cadrenal Therapeutics, Inc.

Equities

CVKD

US1276361086

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-06-26 pm EDT 		5-day change 1st Jan Change
0.472 USD +0.64% Intraday chart for Cadrenal Therapeutics, Inc. -0.94% -36.21%
May. 09 Cadrenal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 09 Cadrenal Therapeutics Receives FDA Orphan Drug Designation for Tecarfarin for Prevention of Thromboembolism and Thrombosis in Patients with LVADs, RVADs, Biventricular Assist Devices, and Total Artificial Hearts CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CADRENAL THERAPEUTICS, INC.
Other Pharmaceuticals
+0.64%-0.94%-36.21%-70.95% - 7.56M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. CVKD Stock
  4. Charts Cadrenal Therapeutics, Inc.
  5. Relative Strength Chart